| BSE: 500680 | Sector: Health care |
| NSE: PFIZER | ISIN Code: INE182A01018 |
| BSE 00:00 | 15 Nov | 2778.75 |
-21.00 (-0.75%) |
OPEN
2790.05 |
HIGH
2802.00 |
LOW
2755.00 |
| NSE 00:00 | 15 Nov | 2775.20 |
-33.55 (-1.19%) |
OPEN
2800.00 |
HIGH
2805.45 |
LOW
2754.80 |
| OPEN | 2790.05 |
| PREVIOUS CLOSE | 2799.75 |
| VOLUME | 1912 |
| 52-Week high | 3840.00 |
| 52-Week low | 1753.20 |
| P/E | 33.51 |
| Mkt Cap.(Rs cr) | 12,713 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Pfizer Limited is engaged in manufacturing marketing trading and export of pharmaceutical products. The company is a subsidiary of Pfizer Inc. the world's premiere biopharmaceutical corporation with annual revenues of $52.5 billion in 2017. Pfizer Limited has a portfolio of over 150 products across 15 therapeutic areas. Its top brands include Prevenar 13 Lyrica Eliquis Enbrel Becosules Gelusil and...> More
| Parameter | Values | ||
| Market Cap | ( cr) |
12,713 | |
| EPS - TTM | () |
[*S] | 82.93 |
| P/E Ratio | (X) | [*S] | 33.51 |
| Face Value | () |
10 | |
| Latest Dividend | (%) | 200.00 | |
| Latest Dividend Date | 29 Aug 2018 | ||
| Dividend Yield | (%) | 0.72 | |
| Book Value / Share | () |
[*S] | 604.61 |
| P/B Ratio | () |
[*S] | 4.60 |
Pfizer Q2 profit dips 13.81% to Rs 958 million, revenue drops marginally
Pfizer cuts revenue forecast on supply shortage at sterile-injections biz
Nifty Pharma index hits over six-month high; Sun Pharma at 14-month high
GAIL, Infosys, Bajaj Finance, Bajaj Finserv from Nifty 50 hit new highs
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Announcement under Regulation 30 (LODR)-Change in Directorate
Unaudited Financial Results For The Quarter Ended September 30 2018.
Board Meeting Intimation for Board Meeting For The Unaudited Financial Results For The Quarter And H
Compliance Certificate - Regulation 7(3) Of The SEBI (LODR) Regulations 2015
Statement Of Investor Complaints For The Quarter Ended September 2018
Particulars ( cr) |
Sep 2018 | Sep 2017 | % Chg |
| Net Sales | 519.74 | 571.11 | -8.99 |
| Other Income | 37.06 | 23.71 | 56.31 |
| Total Income | 556.8 | 594.82 | -6.39 |
| Total Expenses | 389.97 | 403.87 | -3.44 |
| Operating Profit | 166.83 | 190.95 | -12.63 |
| Net Profit | 95.8 | 111.15 | -13.81 |
| Equity Capital | 45.75 | 45.75 | - |
| Company | Price() |
Chg (%) | Mkt Cap ( CR) |
| Abbott India | 7628.30 | 0.35 | 16210.14 |
| Sanofi India | 6140.35 | 0.66 | 14141.23 |
| Natco Pharma | 722.70 | -0.01 | 13351.88 |
| Pfizer | 2778.75 | -0.75 | 12712.78 |
| Jubilant Life | 751.80 | 0.39 | 11976.17 |
| Syngene Intl. | 577.15 | -0.30 | 11543.00 |
| Alembic Pharma | 578.80 | -1.00 | 10910.38 |
|
|
|
| Period | BSE | NSE | Sensex | NIFTY |
| 1 Week | -4.27% | -4.58% | 0.06% | 0.17% |
| 1 Month | -4.07% | -4.25% | 1.13% | 0.99% |
| 3 Month | -4.03% | -4.25% | -6.85% | -7.16% |
| 6 Month | 13.72% | 13.72% | -0.80% | -1.71% |
| 1 Year | 45.60% | 44.71% | 7.63% | 4.93% |
| 3 Year | 13.74% | 13.84% | 37.68% | 36.77% |
| Today's Low/High | 2755.00 |
|
2802.00 |
| Week Low/High | 2755.00 |
|
2920.00 |
| Month Low/High | 2701.00 |
|
2980.00 |
| YEAR Low/High | 1753.20 |
|
3840.00 |
| All TIME Low/High | 25.00 |
|
3840.00 |
Promoters
Banks/FIs
FIIs
Insurance
Mutual Funds
Indian Public
Custodians
Other
